Last 13.05 INR
Change Today -1.20 / -8.42%
Volume 50.0
MDCB On Other Exchanges
Symbol
Exchange
Mumbai
As of 2:34 AM 12/29/14 All times are local (Market data is delayed by at least 15 minutes).

medicamen biotech ltd (MDCB) Snapshot

Open
13.80
Previous Close
14.25
Day High
13.80
Day Low
13.05
52 Week High
09/15/14 - 19.25
52 Week Low
12/30/13 - 6.40
Market Cap
116.3M
Average Volume 10 Days
276.0
EPS TTM
-1.00
Shares Outstanding
8.9M
EX-Date
09/21/10
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDICAMEN BIOTECH LTD (MDCB)

Related News

No related news articles were found.

medicamen biotech ltd (MDCB) Related Businessweek News

No Related Businessweek News Found

medicamen biotech ltd (MDCB) Details

Medicamen Biotech Limited manufactures and markets pharmaceutical formulations in India and internationally. It offers its products in various forms, such as tablets, capsules, oral liquid, dry syrups, ointment, and ORS. The company was incorporated in 1993 and is based in Delhi, India.

Founded in 1993

medicamen biotech ltd (MDCB) Top Compensated Officers

Founder, Managing Director, Director and Memb...
Total Annual Compensation: 5.0M
Whole Time Director and Member of Stakeholder...
Total Annual Compensation: 2.3M
Whole-Time Director and Member of Quality Ass...
Total Annual Compensation: 503.2K
Compensation as of Fiscal Year 2014.

medicamen biotech ltd (MDCB) Key Developments

Medicamen Biotech Ltd. Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Medicamen Biotech Ltd. announced unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the standalone company reported net sales of INR 273.076 million against INR 203.743 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 11.573 million against INR 15.168 million a year ago. Profit from ordinary activities before tax was INR 6.115 million against INR 7.380 million a year ago. Net profit was INR 5.004 million against INR 5.107 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 0.56 against INR 0.60 a year ago. For the six months, the standalone company reported net sales of INR 463.301 million against INR 732.486 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 15.052 million against INR 24.686 million a year ago. Profit from ordinary activities before tax was INR 7.750 million against INR 1.787 million a year ago. Net profit was INR 8.039 million against INR 0.942 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 0.90 against INR 0.11 a year ago.

Medicamen Biotech Ltd. to Report Q2, 2015 Results on Nov 13, 2014

Medicamen Biotech Ltd. announced that they will report Q2, 2015 results on Nov 13, 2014

Medicamen Biotech Ltd., Board Meeting, Nov 13, 2014

Medicamen Biotech Ltd., Board Meeting, Nov 13, 2014. Agenda: To consider & to take on record the unaudited quarterly results for the second quarter & half year ended on September 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCB:IN 13.05 INR -1.20

MDCB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDCB.
View Industry Companies
 

Industry Analysis

MDCB

Industry Average

Valuation MDCB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.2x
Price/Book 0.7x
Price/Cash Flow 6.9x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICAMEN BIOTECH LTD, please visit www.medicamen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.